Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06555094 · ClinicalTrials.gov registry record · NA
Randomized Clinical Trial of Supplementing Brief Psychotherapy With a Mobile App
A NA study of Suicide and Suicidal Ideation, sponsored by Rutgers, The State University of New Jersey.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT06555094: Recruiting NA study of Suicide and Suicidal Ideation, sponsored by Rutgers, The State University of New Jersey.
NCT06555094 is a NA study of Suicide and Suicidal Ideation that is actively recruiting participants, run by Rutgers, The State University of New Jersey. The registered enrollment target is 50 participants, below the 6,989-participant average among 92 other Suicide trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06555094, a NA study of Suicide and Suicidal Ideation, is actively recruiting participants, sponsored by Rutgers, The State University of New Jersey.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this study is to determine whether learning three skills for managing negative emotions and receiving reminders via smartphone to practice these skills reduces how often and how intensely one experiences emotional distress and suicidal thoughts.
Conditions Studied
Interventions
- BEHAVIORAL Ecological momentary assessment (EMA)
- BEHAVIORAL Treatment as usual (TAU)
- BEHAVIORAL Brief skills sessions plus EMI skills practice prompts
Study Locations (1)
New Jersey
- Rutgers University Behavioral Healthcare - Piscataway
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2024-05-14 |
| Est. Completion | 2025-01 |
| Phase | NA |
What NCT06555094 shows while recruiting
NCT06555094 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 6,989-participant average among 92 other Suicide trials with a reported enrollment target (99% lower).
The record links to 3 conditions, with Suicide appearing as the primary indexed condition, and to 3 interventions - of which Ecological momentary assessment (EMA) is the first listed.
NCT06555094 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT06555094 about?
NCT06555094 is a clinical study titled "Randomized Clinical Trial of Supplementing Brief Psychotherapy With a Mobile App". The aim of this study is to determine whether learning three skills for managing negative emotions and receiving reminders via smartphone to practice these skills reduces how often and how intensely one experiences emotional distress and suicidal thoughts.
What is the current status of trial NCT06555094?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-05-14. Estimated completion is 2025-01.
What conditions does trial NCT06555094 study?
This clinical trial studies the following conditions: Suicide, Suicidal Ideation, Suicide Attempt.
What interventions are being tested in trial NCT06555094?
The interventions under investigation include: Ecological momentary assessment (EMA) (BEHAVIORAL), Treatment as usual (TAU) (BEHAVIORAL), Brief skills sessions plus EMI skills practice prompts (BEHAVIORAL).
Who is sponsoring clinical trial NCT06555094?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06555094 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicide
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06555094's enrollment target sits among peer trials
50 72nd of 92 higher than 17 of 92 other Suicide trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Suicide trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
Reducing Suicide Risk Among Aging Caregivers of Persons With AD/ADRD
RECRUITING · NA
-
Functional Connectivity Alterations in Suicidal Patients Among Opioid Users
RECRUITING · NA
-
Suicide Specific Rumination in Veterans
RECRUITING · NA
-
Real-time Examination of Skills and Coping Use in Teen's Everyday Lives
RECRUITING · NA
-
The Use of Voice-Based AI in 988 Crisis Counseling
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI